West Pharmaceutical Services Inc (WST)
320.88
+9.22
(+2.96%)
USD |
NYSE |
Nov 21, 16:00
325.19
+4.31
(+1.34%)
Pre-Market: 09:22
West Pharmaceutical Services Enterprise Value: 22.95B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 22.95B |
| November 20, 2024 | 22.28B |
| November 19, 2024 | 21.74B |
| November 18, 2024 | 21.96B |
| November 15, 2024 | 22.49B |
| November 14, 2024 | 24.20B |
| November 13, 2024 | 24.62B |
| November 12, 2024 | 23.44B |
| November 11, 2024 | 23.44B |
| November 08, 2024 | 23.18B |
| November 07, 2024 | 23.13B |
| November 06, 2024 | 23.57B |
| November 05, 2024 | 23.14B |
| November 04, 2024 | 22.51B |
| November 01, 2024 | 22.63B |
| October 31, 2024 | 22.01B |
| October 30, 2024 | 22.38B |
| October 29, 2024 | 22.77B |
| October 28, 2024 | 22.19B |
| October 25, 2024 | 22.01B |
| October 24, 2024 | 23.66B |
| October 23, 2024 | 20.46B |
| October 22, 2024 | 20.45B |
| October 21, 2024 | 20.54B |
| October 18, 2024 | 20.98B |
| Date | Value |
|---|---|
| October 17, 2024 | 20.64B |
| October 16, 2024 | 20.66B |
| October 15, 2024 | 20.81B |
| October 14, 2024 | 21.12B |
| October 11, 2024 | 21.09B |
| October 10, 2024 | 20.74B |
| October 09, 2024 | 20.48B |
| October 08, 2024 | 20.48B |
| October 07, 2024 | 20.77B |
| October 04, 2024 | 21.21B |
| October 03, 2024 | 21.27B |
| October 02, 2024 | 21.45B |
| October 01, 2024 | 21.45B |
| September 30, 2024 | 21.47B |
| September 27, 2024 | 22.32B |
| September 26, 2024 | 22.04B |
| September 25, 2024 | 21.76B |
| September 24, 2024 | 22.23B |
| September 23, 2024 | 22.01B |
| September 20, 2024 | 22.11B |
| September 19, 2024 | 22.33B |
| September 18, 2024 | 22.19B |
| September 17, 2024 | 21.22B |
| September 16, 2024 | 21.29B |
| September 13, 2024 | 21.57B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.341B
Minimum
Mar 23 2020
34.48B
Maximum
Dec 30 2021
22.79B
Average
23.05B
Median
Oct 27 2023
Enterprise Value Benchmarks
| Repligen Corp | 7.680B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 136.00M |
| Revenue (Quarterly) | 746.90M |
| Total Expenses (Quarterly) | 581.20M |
| EPS Diluted (Quarterly) | 1.85 |
| Gross Profit Margin (Quarterly) | 35.44% |
| Profit Margin (Quarterly) | 18.21% |
| Earnings Yield | 2.10% |
| Operating Earnings Yield | 2.49% |
| Normalized Earnings Yield | 2.166 |